Why is Vivo Bio Tech falling/rising?

As of 25-Jul, Vivo Bio Tech Ltd. is experiencing a decline in its stock price, currently at 35.01, reflecting a decrease of 0.49 or 1.38%. The stock has underperformed its sector today by 1.55% and has seen a trend reversal after two consecutive days of gains. It is trading below all key moving averages, indicating a bearish trend. Additionally, the delivery volume has significantly decreased by 62.66% compared to the 5-day average, suggesting reduced investor participation. Over the past year, the stock has generated a return of -9.65%, while its profits have increased by 187.8%, indicating a disconnect between profitability and stock performance. However, the decrease in promoter holding to 39.06% raises concerns about insider confidence.
In the broader market context, Vivo Bio Tech's short-term performance has been notably weaker than the benchmark, with a 1-week return of -2.48% compared to the Sensex's -0.36%. This underperformance is consistent with its long-term trend, where the stock has lagged behind the BSE500 over various periods. The company's weak long-term fundamentals, such as a -3.36% CAGR growth in net sales over the last five years and a poor EBIT to interest ratio, further contribute to its declining stock price. Overall, the combination of weak investor sentiment, declining promoter confidence, and poor comparative performance against the benchmark are driving the stock's downward movement.